{
    "2020-11-17": [
        [
            {
                "time": "2021-03-15",
                "original_text": "RedHill (RDHL) Closes Enrollment for Phase II Coronavirus Study",
                "features": {
                    "keywords": [
                        "RedHill",
                        "Phase II",
                        "Coronavirus",
                        "Study"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "U.S. hospitals to restrict Lilly COVID-19 antibody treatment due to limited supply",
                "features": {
                    "keywords": [
                        "U.S.",
                        "hospitals",
                        "Lilly",
                        "COVID-19",
                        "antibody",
                        "treatment",
                        "limited supply"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}